Medicago
Medicago is a biopharmaceutical company based in Québec City, Québec, Canada.1)
COVID-19
Medicago is the developer of a plant-based COVID-19 vaccine product called CoVLP, MT-2766 in collaboration with GlaxoSmithKline.2) 3)
A heavily-redacted version of the company's procurement contract with the Government of Canada dated November 9, 2020 was disclosed through a public Access to Information request.
1)
Our locations. Medicago. Retrieved January 18, 2022, from https://archive.ph/yBOmV
2)
Medicago: Plant-based VLP. COVID-19 Vaccine Tracker. Retrieved January 18, 2022, from https://archive.ph/GnpMR
3)
Somos, C. (2021, December 7). Canadian-made, plant-based COVID-19 vaccine sees positive Phase 3 results. CTV News. https://archive.ph/khvOt